US panel weighs whether to OK Merck COVID-19 pill

U.S. health advisers are reviewing Merck's closely watched COVID-19 pill, which could become the first easy-to-use drug for American patients. The FDA asked its outside experts Tuesday whether the agency should authorize the pill. (Nov. 30)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting